Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma to the Uterine Cervix”

117 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 117 results

Not applicableEnded earlyNCT03786107
What this trial is testing

HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib

Who this might be right for
Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerMetastatic Cervical Cancer
Puma Biotechnology, Inc. 1,583
Large-scale testing (Phase 3)Looking for participantsNCT06459687
What this trial is testing

Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Lee's Pharmaceutical Limited 440
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Not applicableNot Yet RecruitingNCT06150222
What this trial is testing

Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study

Who this might be right for
Cancer, CervicalRecurrenceMetastasis
Erasmus Medical Center 350
Testing effectiveness (Phase 2)UnknownNCT05557565
What this trial is testing

A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Qilu Pharmaceutical Co., Ltd. 150
Early research (Phase 1)Ended earlyNCT03277482
What this trial is testing

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Who this might be right for
Recurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more
Dana-Farber Cancer Institute 16
Testing effectiveness (Phase 2)Looking for participantsNCT07051486
What this trial is testing

A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd. 60
Large-scale testing (Phase 3)UnknownNCT05446883
What this trial is testing

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
METASTATIC CERVICAL CANCER
Qilu Pharmaceutical Co., Ltd. 498
Not applicableEnded earlyNCT00978874
What this trial is testing

Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Abramson Cancer Center at Penn Medicine 15
Not applicableNot Yet RecruitingNCT07186868
What this trial is testing

QL706 + Chemo ± Bevacizumab in Anti-PD-(L)1-Resistant R/M Cervical Cancer

Who this might be right for
Recurrent Cervical CancerMetastatic Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 25
Testing effectiveness (Phase 2)UnknownNCT03808857
What this trial is testing

A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive

Who this might be right for
Cervical Cancer
Genor Biopharma Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT00430781
What this trial is testing

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Who this might be right for
Neoplasms, Uterine CervixMetastatic Cervical Cancer
GlaxoSmithKline 228
Large-scale testing (Phase 3)Looking for participantsNCT06459180
What this trial is testing

Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

Who this might be right for
Cervical Cancer
Merck Sharp & Dohme LLC 686
Testing effectiveness (Phase 2)UnknownNCT05247619
What this trial is testing

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Zhejiang Cancer Hospital 49
Testing effectiveness (Phase 2)Study completedNCT00319748
What this trial is testing

Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+1 more
Masonic Cancer Center, University of Minnesota 15
Large-scale testing (Phase 3)Looking for participantsNCT07472153
What this trial is testing

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Who this might be right for
Metastatic Cervical CancerPersistent Cervical CancerRecurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre 120
Large-scale testing (Phase 3)Ended earlyNCT05179239
What this trial is testing

SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

Who this might be right for
Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 31
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Testing effectiveness (Phase 2)Active Not RecruitingNCT05021237
What this trial is testing

Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer

Who this might be right for
Stage IV Cervical Cancer FIGO 2018Adenosquamous Carcinoma of CervixCervical Cancer+1 more
University of Texas Southwestern Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT01026792
What this trial is testing

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI) 38
Load More Results